Sino Biopharmaceutical Limited (SBMFF)
Sino Biopharmaceutical Limited operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Hong Kong, HK. The stock last traded at $0.69, up 0.00% on the session, giving a market capitalisation of $12.38B. On trailing twelve-month figures it carries a trailing P/E of 35.78, a net margin of 7.1%. Its beta of 0.60 implies it has historically moved less than the broad market.
Sino Biopharmaceutical Limited is an investment holding company that operates as an integrated pharmaceutical enterprise. It researches, develops, manufactures, and markets a wide range of modernized Chinese medicines and chemical medicines. The company's therapeutic areas of focus include oncology, liver disease, respiratory, and surgery/pain relief, with its primary market being mainland China. [9, 12, 15, 19]
Sino Biopharmaceutical Limited is most often compared with the following Healthcare names: